mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
-0.048 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
-0.13 |
0.8 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
-0.0088 |
0.8 |